Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


10.12.2018

2 AIDS
2 AIDS Res Hum Retroviruses
3 Clin Infect Dis
1 HIV Med
1 J Clin Invest
2 J Immunol
2 J Infect Dis
1 J Med Virol
2 J Virol
7 Lancet HIV
6 Lancet Infect Dis
1 Nature
1 Neurology
1 PLoS Med
15 PLoS One
2 PLoS Pathog
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. DALOD M, Brooks A
    Broadening our knowledge of the differences between HIV-2 and HIV-1 innate sensing: HIV-2 infected cells selectively express B7-H6 and engage NKp30 on natural killer cells.
    AIDS. 2019;33:153-154.
    PubMed     Text format    

  2. NASREDDINE R, de Wind R, De Wit S, Martin C, et al
    HIV virological failure in a patient with human T-lymphotropic virus type 1-associated leukemia.
    AIDS. 2019;33:159-160.
    PubMed     Text format    


    AIDS Res Hum Retroviruses

  3. HEY-NGUYEN W, Bailey M, Xu Y, Suzuki K, et al
    HIV-1 DNA is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure.
    AIDS Res Hum Retroviruses. 2018 Dec 4. doi: 10.1089/AID.2018.0235.
    PubMed     Text format     Abstract available

  4. MCPHEE E, Grabowski M, Gray R, Ndyanabo A, et al
    The interaction of HIV set-point viral load and subtype on disease progression.
    AIDS Res Hum Retroviruses. 2018 Dec 6. doi: 10.1089/AID.2018.0165.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  5. TEMPIA S, Walaza S, Moyes J, Cohen AL, et al
    Quantifying how Different Clinical Presentations, Levels of Severity and Healthcare Attendance Shape the Burden of Influenza-Associated Illness: a Modeling Study from South Africa.
    Clin Infect Dis. 2018 Dec 2. pii: 5225193. doi: 10.1093/cid/ciy1017.
    PubMed     Text format     Abstract available

  6. AMBROSIONI J, Mosquera M, Miro JM
    Resistance testing for integrase-strand-transfer inhibitors in naive HIV infected individuals.
    Clin Infect Dis. 2018 Dec 6. pii: 5232308. doi: 10.1093/cid/ciy1019.
    PubMed     Text format    

  7. FERRE VM, Gbeasor-Komlanvi FA, Collin G, Dagnra AC, et al
    Prevalence of Human Papillomavirus, HIV and other sexually transmitted infections among men having sex with men in Togo: a national cross-sectional survey.
    Clin Infect Dis. 2018 Dec 6. pii: 5231898. doi: 10.1093/cid/ciy1012.
    PubMed     Text format     Abstract available


    HIV Med

  8. GATEY C, Brun A, Hamet G, Diamantis S, et al
    Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
    HIV Med. 2018 Dec 3. doi: 10.1111/hiv.12697.
    PubMed     Text format     Abstract available


    J Clin Invest

  9. PERCIANI CT, Farah B, Kaul R, Ostrowski MA, et al
    Live-attenuated varicella zoster virus vaccine does not induce HIV target cell activation.
    J Clin Invest. 2018 Dec 4. pii: 124473. doi: 10.1172/JCI124473.
    PubMed     Text format     Abstract available


    J Immunol

  10. WILLIAMS DW, Askew LC, Jones E, Clements JE, et al
    CCR2 Signaling Selectively Regulates IFN-alpha: Role of beta-Arrestin 2 in IFNAR1 Internalization.
    J Immunol. 2018 Nov 30. pii: jimmunol.1800598. doi: 10.4049/jimmunol.1800598.
    PubMed     Text format     Abstract available

  11. GOLEC E, Lind L, Qayyum M, Blom AM, et al
    The Noncoding RNA nc886 Regulates PKR Signaling and Cytokine Production in Human Cells.
    J Immunol. 2018 Dec 5. pii: jimmunol.1701234. doi: 10.4049/jimmunol.1701234.
    PubMed     Text format     Abstract available


    J Infect Dis

  12. MORI M, Leitman E, Walker B, Ndung'u T, et al
    Impact of HLA allele-KIR pairs on HIV clinical outcome in South Africa.
    J Infect Dis. 2018 Dec 6. pii: 5231981. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. MANN LM, Llata E, Flagg EW, Hong J, et al
    Trends of Anogenital Warts Among Sexually Transmitted Disease Clinic Patients - Sexually Transmitted Disease Surveillance Network, United States, 2010-2016.
    J Infect Dis. 2018 Nov 29. pii: 5219029. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  14. SINGH L, Bell TG, Yousif M, Kramvis A, et al
    Response of hepatitis B virus to anti-retroviral treatment containing lamivudine in HBsAg-positive and HBsAg-negative HIV-positive South African adults.
    J Med Virol. 2018 Dec 4. doi: 10.1002/jmv.25375.
    PubMed     Text format     Abstract available


    J Virol

  15. DANTAS E, Diaz FE, Gerber PP, Varese A, et al
    Histidine-rich glycoprotein inhibits HIV-1 infection in a pH-dependent manner.
    J Virol. 2018 Dec 5. pii: JVI.01749-18. doi: 10.1128/JVI.01749.
    PubMed     Text format     Abstract available

  16. ZHANG Y, Chapman JH, Ulcay A, Sutton RE, et al
    Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.
    J Virol. 2018 Dec 5. pii: JVI.01446-18. doi: 10.1128/JVI.01446.
    PubMed     Text format     Abstract available


    Lancet HIV

  17. COTTRELL ML, Dumond JB
    The potential pitfalls of PrEP.
    Lancet HIV. 2018 Nov 29. pii: S2352-3018(18)30318.
    PubMed     Text format    

  18. COUSINS S
    Blue Diamond Society: working with Nepal's LGBT community.
    Lancet HIV. 2018;5:e615.
    PubMed     Text format    

  19. COHEN SE, Sachdev D, Lee SA, Scheer S, et al
    Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.
    Lancet HIV. 2018 Nov 29. pii: S2352-3018(18)30288.
    PubMed     Text format     Abstract available

  20. PHILLIPS AN, Venter F, Havlir D, Pozniak A, et al
    Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study.
    Lancet HIV. 2018 Nov 29. pii: S2352-3018(18)30317.
    PubMed     Text format     Abstract available

  21. DORWARD J, Hamers RL
    Dolutegravir in sub-Saharan Africa: context is crucial.
    Lancet HIV. 2018 Nov 29. pii: S2352-3018(18)30331.
    PubMed     Text format    

  22. THE LANCET HIV
    Microelimination could be a big deal for HCV and HIV services.
    Lancet HIV. 2018;5:e605.
    PubMed     Text format    

  23. COUSINS S
    Reaching Nepal's mobile population at risk of HIV.
    Lancet HIV. 2018;5:e613-e614.
    PubMed     Text format    


    Lancet Infect Dis

  24. DELANY-MORETLWE S, Lombard C, Baron D, Bekker LG, et al
    Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.
    Lancet Infect Dis. 2018;18:1241-1250.
    PubMed     Text format     Abstract available

  25. BURKI T
    HIV in China: a changing epidemic.
    Lancet Infect Dis. 2018;18:1311-1312.
    PubMed     Text format    


  26. Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study.
    Lancet Infect Dis. 2018;18:1329-1349.
    PubMed     Text format     Abstract available

  27. GENG EH, Glidden DV, Padian N
    Strengthening HIV-prevention trials: a dose of implementation science?
    Lancet Infect Dis. 2018;18:1166-1168.
    PubMed     Text format    

  28. PARASKEVIS D, Hatzakis A
    Global molecular epidemiology of HIV-1: the chameleon challenge.
    Lancet Infect Dis. 2018 Nov 30. pii: S1473-3099(18)30687.
    PubMed     Text format    

  29. HEMELAAR J, Elangovan R, Yun J, Dickson-Tetteh L, et al
    Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis.
    Lancet Infect Dis. 2018 Nov 30. pii: S1473-3099(18)30647.
    PubMed     Text format     Abstract available


    Nature

  30. GRABER-STIEHL I
    The silent epidemic killing more people than HIV, malaria or TB.
    Nature. 2018;564:24-26.
    PubMed     Text format    


    Neurology

  31. SILVERMAN A, O'Meara T, Le L, Robertson K, et al
    Residency Training: Progressive gait difficulty and incontinence in a 40-year-old man with HIV.
    Neurology. 2018;91:1065-1070.
    PubMed     Text format    


    PLoS Med

  32. KITYO C, Szubert AJ, Siika A, Heyderman R, et al
    Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
    PLoS Med. 2018;15:e1002706.
    PubMed     Text format     Abstract available


    PLoS One

  33. RESTAR A, Nguyen M, Nguyen K, Adia A, et al
    Trends and emerging directions in HIV risk and prevention research in the Philippines: A systematic review of the literature.
    PLoS One. 2018;13:e0207663.
    PubMed     Text format     Abstract available

  34. SHARMA P, Shahabi K, Spitzer R, Farrugia M, et al
    Cervico-vaginal inflammatory cytokine alterations after intrauterine contraceptive device insertion: A pilot study.
    PLoS One. 2018;13:e0207266.
    PubMed     Text format     Abstract available

  35. JUANBELTZ R, Perez-Garcia A, Aguinaga A, Martinez-Baz I, et al
    Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain.
    PLoS One. 2018;13:e0208554.
    PubMed     Text format     Abstract available

  36. YUSEFZADEH H, Didarloo A, Nabilou B
    Provider knowledge and performance in medication injection safety in anesthesia: A mixed method prospective crosses sectional study.
    PLoS One. 2018;13:e0207572.
    PubMed     Text format     Abstract available

  37. FLAMAR AL, Bonnabau H, Zurawski S, Lacabaratz C, et al
    HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates.
    PLoS One. 2018;13:e0207794.
    PubMed     Text format     Abstract available

  38. GREENE ML, Tan JY, Weiser SD, Christopoulos K, et al
    Patient and provider perceptions of a comprehensive care program for HIV-positive adults over 50 years of age: The formation of the Golden Compass HIV and aging care program in San Francisco.
    PLoS One. 2018;13:e0208486.
    PubMed     Text format     Abstract available

  39. HOGG RS, Heath K, Lima VD, Nosyk B, et al
    Correction: Disparities in the Burden of HIV/AIDS in Canada.
    PLoS One. 2018;13:e0209045.
    PubMed     Text format     Abstract available

  40. MALLITT KA, Wilson DP, Jansson J, McDonald A, et al
    Identifying missed clinical opportunities for the earlier diagnosis of HIV in Australia, a retrospective cohort data linkage study.
    PLoS One. 2018;13:e0208323.
    PubMed     Text format     Abstract available

  41. LI WY, Chen M, Huang SW, Jen IA, et al
    Molecular epidemiology of HIV-1 infection among men who have sex with men in Taiwan from 2013 to 2015.
    PLoS One. 2018;13:e0202622.
    PubMed     Text format     Abstract available

  42. SETTERGREN SK, Mujaya S, Rida W, Kajula LJ, et al
    Cluster randomized trial of comprehensive gender-based violence programming delivered through the HIV/AIDS program platform in Mbeya Region, Tanzania: Tathmini GBV study.
    PLoS One. 2018;13:e0206074.
    PubMed     Text format     Abstract available

  43. WERNER RN, Gaskins M, Nast A, Dressler C, et al
    Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection - A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis.
    PLoS One. 2018;13:e0208107.
    PubMed     Text format     Abstract available

  44. TAKAH NF, Atem JA, Aminde LN, Malisheni M, et al
    The impact of approaches in improving male partner involvement in the prevention of mother-to-child transmission of HIV on the uptake of safe infant feeding practices by HIV positive women in sub-Saharan Africa. A systematic review and meta-analysis.
    PLoS One. 2018;13:e0207060.
    PubMed     Text format     Abstract available

  45. EVERSON F, Genis A, Ogundipe T, De Boever P, et al
    Treatment with a fixed dose combination antiretroviral therapy drug containing tenofovir, emtricitabine and efavirenz is associated with cardioprotection in high calorie diet-induced obese rats.
    PLoS One. 2018;13:e0208537.
    PubMed     Text format     Abstract available

  46. PEEBLES K, McClelland RS, Overbaugh J, Richardson BA, et al
    Higher prevalence of viral control in HIV-1-infected women in serodiscordant relationships.
    PLoS One. 2018;13:e0208401.
    PubMed     Text format     Abstract available

  47. ABADIE R, Goldenberg S, Welch-Lazoritz M, Fisher CB, et al
    Establishing trust in HIV/HCV research among people who inject drugs (PWID): Insights from empirical research.
    PLoS One. 2018;13:e0208410.
    PubMed     Text format     Abstract available


    PLoS Pathog

  48. COLIN P, Zhou Z, Staropoli I, Garcia-Perez J, et al
    CCR5 structural plasticity shapes HIV-1 phenotypic properties.
    PLoS Pathog. 2018;14:e1007432.
    PubMed     Text format     Abstract available

  49. WELLES HC, Jennewein MF, Mason RD, Narpala S, et al
    Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.
    PLoS Pathog. 2018;14:e1007395.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  50. SCHULZE-GAHMEN U, Hurley JH
    Structural mechanism for HIV-1 TAR loop recognition by Tat and the super elongation complex.
    Proc Natl Acad Sci U S A. 2018 Dec 4. pii: 1806438115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: